Healthcare Stocks

Deals of the day-Mergers and acquisitions

  • December 01, 2022 08:02 AM PST | Reuters
 Deals of the day-Mergers and acquisitions

(Adds Axo, Univar Solutions, PLT Energia, Kronospan, Aerojet Rocketdyne, Vivendi; updates Telecom Italia) Nov 30 (Reuters) - The following bids, mergers, acquisitions and disposals were reported by

Read More...

BRIEF-Simply Better Brands Announces Third Quarter 2022 Financial Results And Increases Year-To-Go Outlook

BRIEF-Simply Better Brands Announces Third Quarter 2022 Financial Results And Increases Year-To-Go Outlook

  • November 30, 2022 09:14 AM PST | Reuters

Nov 29 (Reuters) - Simply Better Brands Corp: * SIMPLY BETTER BRANDS CORP ANNOUNCES THIRD QUARTER 2022 FINANCIAL RESULTS AND INCREASES YEAR-TO-GO OUTLOOK * SIMPLY BETTER BRANDS CORP SEES 2022 EXPECTED

Read More...
BRIEF-Portage Biotech Announces Results For Fiscal Quarter Ended September 30, 2022

BRIEF-Portage Biotech Announces Results For Fiscal Quarter Ended September 30, 2022

  • November 30, 2022 09:04 AM PST | Reuters

Nov 29 (Reuters) - Portage Biotech Inc: * PORTAGE BIOTECH ANNOUNCES RESULTS FOR FISCAL QUARTER ENDED SEPTEMBER 30, 2022 * PORTAGE BIOTECH INC - QTRLY LOSS PER SHARE $0.06 Source text for Eikon:

Read More...
BRIEF-Numinus Wellness Reports Q4 2022 And Annual Results

BRIEF-Numinus Wellness Reports Q4 2022 And Annual Results

  • November 30, 2022 08:47 AM PST | Reuters

Nov 29 (Reuters) - Numinus Wellness Inc: * NUMINUS WELLNESS INC'S Q4 REVENUE ROSE 643% TO C$4.2 MILLION * Q4 ADJUSTED LOSS PER SHARE C$0.04 * QTRLY LOSS PER SHARE $0.10 Source text for Eikon: Further

Read More...
BRIEF-Alamos Gold Reports Fatality At Its Young-Davidson Mine

BRIEF-Alamos Gold Reports Fatality At Its Young-Davidson Mine

  • November 30, 2022 11:22 AM EST | Reuters

Nov 29 (Reuters) - Alamos Gold Inc: * ALAMOS GOLD REPORTS FATALITY AT ITS YOUNG-DAVIDSON MINE * ANNOUNCE DEATH OF AN EMPLOYEE FOLLOWING AN ACCIDENT UNDERGROUND AT YOUNG-DAVIDSON MINE THIS AFTERNOON *

Read More...
BRIEF-Franchise Global Reports Third Quarter 2022 Financial Results

BRIEF-Franchise Global Reports Third Quarter 2022 Financial Results

  • November 30, 2022 09:33 AM EST | Reuters

Nov 29 (Reuters) - Franchise Global Health Inc: * FRANCHISE GLOBAL HEALTH INC Q3 REVENUE INCREASED BY $11.7 MILLION Y-O-Y TO $11.9 MILLION * NET LOSS FOR Q3 OF 2022 WAS $3.2 MILLION Source text for

Read More...
What to Watch in the Day Ahead - Wednesday, November 30

What to Watch in the Day Ahead - Wednesday, November 30

  • November 30, 2022 06:30 AM PST | Reuters

(The Day Ahead is an email and PDF publication that includes the day's major stories and events, analyses and other features. To receive The Day Ahead, Eikon users can register at . Thomson One users

Read More...
BRIEF-Valens Shareholders Vote In Favour Of The Arrangement With SNDL

BRIEF-Valens Shareholders Vote In Favour Of The Arrangement With SNDL

  • November 30, 2022 09:15 AM EST | Reuters

Nov 29 (Reuters) - Valens Company Inc: * VALENS SHAREHOLDERS VOTE IN FAVOUR OF THE ARRANGEMENT WITH SNDL Source text for Eikon: Further company coverage:

Read More...
BRIEF-Simply Better Brands Announces Third Quarter 2022 Financial Results And Increases Year-To-Go Outlook

BRIEF-Simply Better Brands Announces Third Quarter 2022 Financial Results And Increases Year-To-Go Outlook

  • November 30, 2022 09:14 AM EST | Reuters

Nov 29 (Reuters) - Simply Better Brands Corp: * SIMPLY BETTER BRANDS CORP ANNOUNCES THIRD QUARTER 2022 FINANCIAL RESULTS AND INCREASES YEAR-TO-GO OUTLOOK * SIMPLY BETTER BRANDS CORP SEES 2022 EXPECTED

Read More...
Portage Biotech Inc <PRTG.O>: Losses of 6  cents announced for second quarter

Portage Biotech Inc <PRTG.O>: Losses of 6  cents announced for second quarter

  • November 30, 2022 09:05 AM EST | Reuters

29 November 2022 10:05 p.m. ​All figures in US dollars. The loss announced by Portage Biotech Inc in the second quarter were higher than the Refinitiv mean estimate of losses. The company reported

Read More...
Portage Biotech Inc reports results for the quarter ended in September - Earnings Summary

Portage Biotech Inc reports results for the quarter ended in September - Earnings Summary

  • November 30, 2022 09:04 AM EST | Reuters

* Portage Biotech Inc reported a quarterly adjusted loss of 6 cents​​ per share for the quarter ended in September. The mean expectation of three analysts for the quarter was for a loss of 29 cents

Read More...

Frequently Asked Questions

There are multiple ways to look at any stock. It may include looking at fundamentals like dividends, earnings over the last few years, and ratios like price-to-earnings (P/E). The other way might be to look at what the future may hold. In the event of a large-scale demand in the future for a particular drug or vaccine that a company has produced or is likely to produce in the near term, the company's stock may find more backers. A look at what the company provides in the market, which can include hospital services, might be a good way to look at healthcare stocks.

There is a variety of choices available to the investor. Stocks represent companies that operate in sectors like healthcare, oil and gas, cannabis, and the list is long. The best stocks may relate to a particular industry, for example, the clean energy sector which has participants like Brookfield Renewable Partners, and Northland Power, or they can be a diversified mix of clean energy stocks and other sectors like oil and energy. In order to pick the best, the investor must study a little about the near-term market prospects for the related sector.

Considering the market environment at the time of writing this, Verde Agritech PLC (TSX: NPK) appears to be one of the fastest-growing stocks in Canada, with a price-to-earnings (P/E) ratio of 114.3. This crop nutrition and input stock has zoomed by over 450 per cent in the last 12 months. On the financial front, Verde Agritech expanded its 2021 net profit by 540 per cent year-on-year (YoY), and it expects 2022 revenue to reach C$ 72.26 million. However, investors should note that a stock’s performance can change depending on market conditions.

Healthcare stocks represent entities that provide arguably one of the most basic necessities to the wider world. They become even more crucial at the time of a pandemic or a large-scale disease outbreak in any particular region. Healthcare remains a growing sector as cures for all diseases have yet to be identified, and new ones like Covid-19 can crop up at any time. This makes healthcare stocks an interesting watch for a lot of investors.

We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it. OK